Risk stratification of LA‐NPC during chemoradiotherapy based on clinical classification and TVRR

Risk stratification of LA‐NPC during chemoradiotherapy based on clinical classification and TVRR

Abstract Purpose To investigate the correlation between tumor volume reduction rate (TVRR) and prognosis in patients with diverse clinical types of nasopharyngeal carcinoma (NPC) undergoing chemoradiotherapy, thereby aptly categorizing risks and directing the personalized treatment of NPC. Materials...

Full description

Bibliographic Details
Main Authors:	Qianlong Tang, Chaorong Mei, Bei Huang, Rui Huang, Le Kang, Ailin Chen, Na lei, Pengcheng Deng, Shouyan Ying, Peng Zhang, Yuan Qin
Format:	Article
Language:	English
Published:	Wiley 2024-02-01
Series:	Cancer Medicine
Subjects:	clinical typing nasopharyngeal carcinoma prognosis risk stratification tumor volume reduction rate
Online Access:	https://doi.org/10.1002/cam4.7029

Similar Items

Effects of Surgery Combined with Chemoradiotherapy on Short- and Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma
by: Weng JJ, et al.
Published: (2020-08-01)

Combined Association of Tumoral PD-L1 Expression and Pretreatment Presence of Epstein-Barr Virus DNA With Risk Stratification and Prognosis of Patients With Nasopharyngeal Carcinoma
by: Xiaoyu Li, et al.
Published: (2022-01-01)

An improved advanced fragment analysis-based classification and risk stratification of pediatric acute lymphoblastic leukemia
by: Yanran Sun, et al.
Published: (2019-04-01)

Residual Volume of Lymph Nodes During Chemoradiotherapy Based Nomogram to Predict Survival of Nasopharyngeal Carcinoma Patient Receiving Induction Chemotherapy
by: Yan Li, et al.
Published: (2021-09-01)

Molecular Stratification of Childhood Ependymomas as a Basis for Personalized Diagnostics and Treatment
by: Margarita Zaytseva, et al.
Published: (2021-10-01)

A new prognostic histopathologic classification of nasopharyngeal carcinoma
by: Hai-Yun Wang, et al.
Published: (2016-05-01)

Risk stratification of thromboembolic complications development in surgical patients
by: K. I. Popandopulo, et al.
Published: (2020-03-01)

Clinical picture, management and risk stratification in patients with cardiogenic shock: does gender matter?
by: Elena Collado-Lledó, et al.
Published: (2020-04-01)

Prognostic significance of the novel nutrition-inflammation marker of lymphocyte–C-reactive protein ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy
by: Xin Hua, et al.
Published: (2023-07-01)

Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis
by: Ching-Feng Lien, et al.
Published: (2022-09-01)

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
by: Chung-Chun Wu, et al.
Published: (2019-11-01)

A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma
by: Zhang S, et al.
Published: (2018-06-01)

Gastrointestinal Stromal Tumor: Clinicopathological Features, Management, and Comparison of Three Risk Stratification Schemes
by: Wedad B. Hashem, et al.
Published: (2021-12-01)

Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA
by: Xiaofei Yuan, et al.
Published: (2022-08-01)

Establishment and verification of a radiomics nomogram to predict distant metastasis in patients with descending type of nasopharyngeal carcinoma
by: Qin Yang, et al.
Published: (2022-09-01)

Epstein–Barr virus DNA change level combined with tumor volume reduction ratio after inductive chemotherapy as a better prognostic predictor in locally advanced nasopharyngeal carcinoma
by: Zhong‐zheng Xiang, et al.
Published: (2023-01-01)

Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
by: Yu-Xiang He, et al.
Published: (2016-11-01)

Risk stratification and beneficiary selection among elderly nasopharyngeal carcinoma patients from concurrent chemoradiotherapy combined with induction chemotherapy
by: Shuiqing He, et al.
Published: (2023-05-01)

Social stratification : trends and processes /
by: Lambert, Paul
Published: (c201)

Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram
by: Jianming Ding, et al.
Published: (2024-03-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
by: Yi Tian Png, et al.
Published: (2021-02-01)

Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study
by: Jingjin Weng, et al.
Published: (2017-10-01)

DOM stratification and characteristics versus thermal stratification – A case study in the Panjiakou Reservoir, China
by: Mengjiao Wei, et al.
Published: (2022-08-01)

Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
by: Argyro Vraka, et al.
Published: (2023-06-01)

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment
by: Wenhua Liang, et al.
Published: (2016-11-01)

The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients
by: Efsun Somay, et al.
Published: (2024-01-01)

LMP-1 and Nasopharyngeal Carcinoma (NPC)
by: Anggun Indah Budiningrum, et al.
Published: (2014-06-01)

Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
by: Cui-Dai Zhang, et al.
Published: (2021-06-01)

Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
by: Nai-Bin Chen, et al.
Published: (2020-11-01)

Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients
by: Aifen Lin, et al.
Published: (2019-02-01)

Identification of Risk Factors Associated with Nasopharyngeal Carcinoma (NPC) in the Pahang State of Malaysia Hospitals
by: Azmir Ahmad, et al.
Published: (2022-04-01)

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
by: Jin-Hao Yang, et al.
Published: (2021-05-01)

Stratification and Diagrammatic Storytelling. An Encounter with 'Under the Dome'
by: Jon McKenzie
Published: (2015-06-01)

Etiology and management of nasopharyngeal hemorrhage after radiotherapy for nasopharyngeal carcinoma
by: Zhan J, et al.
Published: (2019-03-01)

Gut microbiota profile of COVID-19 patients: Prognosis and risk stratification (MicroCOVID-19 study)
by: José Guilherme Nobre, et al.
Published: (2022-11-01)

Establishment of age group classification for risk stratification in glioma patients
by: Zhiying Lin, et al.
Published: (2020-08-01)

Integrating Tumor Stroma Biomarkers With Clinical Indicators for Colon Cancer Survival Stratification
by: Yong Chen, et al.
Published: (2020-12-01)

Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
by: Erkan Topkan, et al.
Published: (2020-11-01)

Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients
by: Xiang Li, et al.
Published: (2023-06-01)

Long‐term risk stratification for hospitalized patients with acute heart failure at a single rural cardiovascular centre
by: Keisuke Satogami, et al.
Published: (2023-06-01)